{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:37:49Z","timestamp":1790127469177,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.sleep.2024.09.045","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T02:59:17Z","timestamp":1727837957000},"page":"315-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Signal detection of drugs associated with obstructive and central sleep apnoea"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6619-4130","authenticated-orcid":false,"given":"C.","family":"Jambon-Barbara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Revol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hlavaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Joyeux-Faure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Borel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Cracowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Pepin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8427-8573","authenticated-orcid":false,"given":"C.","family":"Khouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2024.09.045_bib1","article-title":"Obstructive sleep apnoea syndrome","volume":"1","author":"L\u00e9vy","year":"2015","journal-title":"Nat Rev Dis Primer"},{"issue":"8","key":"10.1016\/j.sleep.2024.09.045_bib2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S2213-2600(19)30198-5","article-title":"Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis","volume":"7","author":"Benjafield","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.sleep.2024.09.045_bib3","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jacc.2021.05.048","article-title":"Sleep disordered breathing and cardiovascular disease: JACC state-of-the-art review","volume":"78","author":"Cowie","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.sleep.2024.09.045_bib4","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000988","article-title":"Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American heart association","volume":"144","author":"Yeghiazarians","year":"2021","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.sleep.2024.09.045_bib5","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01788-2021","article-title":"Novel avenues to approach non-CPAP therapy and implement comprehensive obstructive sleep apnoea care","volume":"59","author":"P\u00e9pin","year":"2022","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.sleep.2024.09.045_bib6","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/bcp.13153","article-title":"Impact of concomitant medications on obstructive sleep apnoea","volume":"83","author":"Jullian-Desayes","year":"2017","journal-title":"Br J Clin Pharmacol"},{"issue":"20","key":"10.1016\/j.sleep.2024.09.045_bib7","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/j.jacc.2018.03.447","article-title":"Ticagrelor and central sleep apnea","volume":"71","author":"Revol","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.sleep.2024.09.045_bib8","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/sim.4780071110","article-title":"Prescription sequence analysis: a new and fast method for assessing certain adverse reactions of prescription drugs in large populations","volume":"7","author":"Petri","year":"1988","journal-title":"Stat Med"},{"issue":"8","key":"10.1016\/j.sleep.2024.09.045_bib9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s40264-020-00940-5","article-title":"Detecting medicine safety signals using prescription sequence symmetry analysis of a national prescribing data set","volume":"43","author":"King","year":"2020","journal-title":"Drug Saf"},{"issue":"9","key":"10.1016\/j.sleep.2024.09.045_bib10","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s40264-018-0668-9","article-title":"Non-bleeding adverse events with the use of direct oral anticoagulants: a sequence symmetry analysis","volume":"41","author":"Maura","year":"2018","journal-title":"Drug Saf"},{"issue":"6","key":"10.1016\/j.sleep.2024.09.045_bib11","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/14740338.2017.1325463","article-title":"Methods for safety signal detection in healthcare databases: a literature review","volume":"16","author":"Arnaud","year":"2017","journal-title":"Expert Opin Drug Saf"},{"issue":"7","key":"10.1016\/j.sleep.2024.09.045_bib12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10654-017-0281-8","article-title":"Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies","volume":"32","author":"Lai","year":"2017","journal-title":"Eur J Epidemiol"},{"issue":"6","key":"10.1016\/j.sleep.2024.09.045_bib13","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/clpt.2012.50","article-title":"Novel data mining methodologies for adverse drug event discovery and analysis","volume":"91","author":"Harpaz","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.sleep.2024.09.045_bib14","article-title":"Characterization and corroboration of safety signals identified from the US food and drug administration adverse event reporting system, 2008-19: cross sectional study","volume":"379","author":"Dhodapkar","year":"2022","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.sleep.2024.09.045_bib15","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/dom.14982","article-title":"Identifying diabetogenic drugs using real world health care databases: a Danish and Australian symmetry analysis","volume":"25","author":"Lund","year":"2023","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"10.1016\/j.sleep.2024.09.045_bib16","doi-asserted-by":"crossref","first-page":"W","DOI":"10.7326\/0003-4819-147-8-200710160-00010-w1","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration","volume":"147","author":"Vandenbroucke","year":"2007","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.sleep.2024.09.045_bib17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s40264-024-01421-9","article-title":"The reporting of a disproportionality analysis for drug safety signal detection using individual case safety reports in PharmacoVigilance (READUS-PV): development and statement","volume":"47","author":"Fusaroli","year":"2024","journal-title":"Drug Saf"},{"issue":"6","key":"10.1016\/j.sleep.2024.09.045_bib18","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40264-024-01423-7","article-title":"The REporting of A disproportionality analysis for DrUg safety signal detection using individual case safety reports in PharmacoVigilance (READUS-PV): explanation and elaboration","volume":"47","author":"Fusaroli","year":"2024","journal-title":"Drug Saf"},{"issue":"8","key":"10.1016\/j.sleep.2024.09.045_bib19","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/pds.4233","article-title":"The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology","volume":"26","author":"Bezin","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"10.1016\/j.sleep.2024.09.045_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-0038-1634527","article-title":"Automatic record hash coding and linkage for epidemiological follow-up data confidentiality","volume":"37","author":"Quantin","year":"1998","journal-title":"Methods Inf Med"},{"issue":"4","key":"10.1016\/j.sleep.2024.09.045_bib21","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.respe.2010.04.005","article-title":"French national health insurance information system and the permanent beneficiaries sample","volume":"58","author":"Tuppin","year":"2010","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"1","key":"10.1016\/j.sleep.2024.09.045_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s40264-013-0124-9","article-title":"Comparing time to adverse drug reaction signals in a spontaneous reporting database and a claims database: a case study of rofecoxib-induced myocardial infarction and rosiglitazone-induced heart failure signals in Australia","volume":"37","author":"Wahab I","year":"2014","journal-title":"Drug Saf"},{"key":"10.1016\/j.sleep.2024.09.045_bib23","article-title":"Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people","volume":"8","author":"Semenzato","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.sleep.2024.09.045_bib24","first-page":"272","article-title":"Etude des algorithmes de d\u00e9finition de pathologies dans le Syst\u00e8me Nationale d'Information Inter-R\u00e9gimes de l'Assurance Maladie (SNIIRAM)","author":"Quantin","year":"2015","journal-title":"Caisse National d\u2019Assurance Maladie"},{"key":"10.1016\/j.sleep.2024.09.045_bib25","unstructured":"G\u00e9odes - Sant\u00e9 publique France - Indicateurs : cartes, donn\u00e9es et graphiques [Internet]. [cited 2022 Oct 25]. Available from: https:\/\/geodes.santepubliquefrance.fr\/#view=map2&c=indicator."},{"issue":"6","key":"10.1016\/j.sleep.2024.09.045_bib26","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.chest.2022.02.013","article-title":"Relationship between CPAP termination and all-cause mortality: a French nationwide database analysis","volume":"161","author":"P\u00e9pin","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.sleep.2024.09.045_bib27","article-title":"CPAP resumption after a first termination and impact on all-cause mortality in France","author":"P\u00e9pin","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.sleep.2024.09.045_bib28","article-title":"Impact of beta-blockers on mortality and cardiovascular disease outcomes in patients with obstructive sleep apnoea: a population-based cohort study in target trial emulation framework","volume":"33","author":"Chen","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.sleep.2024.09.045_bib29","series-title":"Practical aspects of signal detection in pharmacovigilance: report of CIOMS Working Group VIII","first-page":"143","year":"2010"},{"key":"10.1016\/j.sleep.2024.09.045_bib30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2288-14-66","article-title":"The performance of sequence symmetry analysis as a tool for post-market surveillance of newly marketed medicines: a simulation study","volume":"14","author":"Pratt","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"10.1016\/j.sleep.2024.09.045_bib31","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00001648-199609000-00005","article-title":"Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis","volume":"7","author":"Hallas","year":"1996","journal-title":"Epidemiol Camb Mass"},{"issue":"6","key":"10.1016\/j.sleep.2024.09.045_bib32","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.1736","article-title":"Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis","volume":"18","author":"Tsiropoulos","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6632","key":"10.1016\/j.sleep.2024.09.045_bib33","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1136\/bmj.296.6632.1313","article-title":"Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates","volume":"296","author":"Morris","year":"1988","journal-title":"Br Med J Clin Res"},{"issue":"4","key":"10.1016\/j.sleep.2024.09.045_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002280050466","article-title":"A Bayesian neural network method for adverse drug reaction signal generation","volume":"54","author":"Bate","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.sleep.2024.09.045_bib35","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s40264-018-00792-0","article-title":"A comparison study of algorithms to detect drug\u2013adverse event associations: frequentist, bayesian, and machine-learning approaches","volume":"42","author":"Pham","year":"2019","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.sleep.2024.09.045_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0962280211403604","article-title":"Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery","volume":"22","author":"Nor\u00e9n","year":"2013","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"10.1016\/j.sleep.2024.09.045_bib37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11325-008-0208-4","article-title":"Hypoxemia in patients on chronic opiate therapy with and without sleep apnea","volume":"13","author":"Mogri","year":"2009","journal-title":"Sleep Breath Schlaf Atm"},{"issue":"4","key":"10.1016\/j.sleep.2024.09.045_bib38","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/0310057X1103900405","article-title":"Opioids, ventilation and acute pain management","volume":"39","author":"Macintyre","year":"2011","journal-title":"Anaesth Intensive Care"},{"issue":"6","key":"10.1016\/j.sleep.2024.09.045_bib39","first-page":"645","article-title":"The epidemic of opioid use: implications for the sleep physician","volume":"10","author":"Lee-Iannotti","year":"2014","journal-title":"J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med."},{"issue":"2","key":"10.1016\/j.sleep.2024.09.045_bib40","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1164\/ajrccm.151.2.7842205","article-title":"Triazolam in patients with obstructive sleep apnea","volume":"151","author":"Berry","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.sleep.2024.09.045_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsz301","article-title":"GABA and glycine neurons from the ventral medullary region inhibit hypoglossal motoneurons","volume":"43","author":"Dergacheva","year":"2020","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2024.09.045_bib42","article-title":"Effects of opioid, hypnotic and sedating medications on sleep\u2010disordered breathing in adults with obstructive sleep apnoea","volume":"7","author":"Mason","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.sleep.2024.09.045_bib43","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01344-2017","article-title":"Role of common hypnotics on the phenotypic causes of obstructive sleep apnoea: paradoxical effects of zolpidem","volume":"50","author":"Carberry","year":"2017","journal-title":"Eur Respir J"},{"issue":"18","key":"10.1016\/j.sleep.2024.09.045_bib44","doi-asserted-by":"crossref","first-page":"9720","DOI":"10.3390\/ijerph18189720","article-title":"The association between use of benzodiazepine receptor agonists and the risk of obstructive sleep apnea: a nationwide population-based nested case-control study","volume":"18","author":"Hsu","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.sleep.2024.09.045_bib45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/atm.ATM_198_18","article-title":"The effect of nonbenzodiazepines sedative hypnotics on apnea-hypopnea index: a meta-analysis","volume":"14","author":"Nigam","year":"2019","journal-title":"Ann Thorac Med"},{"issue":"4","key":"10.1016\/j.sleep.2024.09.045_bib46","doi-asserted-by":"crossref","first-page":"757","DOI":"10.5665\/sleep.5622","article-title":"Zopiclone increases the arousal threshold without impairing genioglossus activity in obstructive sleep apnea","volume":"39","author":"Carter","year":"2016","journal-title":"Sleep"},{"issue":"10357","key":"10.1016\/j.sleep.2024.09.045_bib47","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(22)00879-0","article-title":"Insomnia","volume":"400","author":"Perlis","year":"2022","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.sleep.2024.09.045_bib48","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1183\/09031936.95.08020230","article-title":"The effects of the GABA agonist, baclofen, on sleep and breathing","volume":"8","author":"Finnimore","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1016\/j.sleep.2024.09.045_bib49","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2147\/NSS.S362205","article-title":"The combination of betahistine and oxybutynin increases respiratory control sensitivity (loop gain) in people with obstructive sleep apnea: a randomized, placebo-controlled trial","volume":"14","author":"Messineo","year":"2022","journal-title":"Nat Sci Sleep"},{"key":"10.1016\/j.sleep.2024.09.045_bib50","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.79986","article-title":"Evolving roles of spontaneous reporting systems to assess and monitor drug safety","author":"Raschi","year":"2019","journal-title":"Pharmacovigilance. IntechOpen"},{"issue":"3","key":"10.1016\/j.sleep.2024.09.045_bib51","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/fcp.12264","article-title":"Can drugs induce or aggravate sleep apneas? A case\u2013noncase study in VigiBase \u00ae , the WHO pharmacovigilance database","volume":"31","author":"Linselle","year":"2017","journal-title":"Fundam Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.sleep.2024.09.045_bib52","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMc1601662","article-title":"Cheyne-Stokes respiration, chemoreflex, and ticagrelor-related dyspnea","volume":"375","author":"Giannoni","year":"2016","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.sleep.2024.09.045_bib53","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1111\/bcp.13967","article-title":"Ticagrelor and central sleep apnoea: impact of withdrawal and reintroduction","volume":"85","author":"Puel","year":"2019","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.sleep.2024.09.045_bib54","first-page":"1179","article-title":"Ticagrelor-associated shift from obstructive to central sleep apnea: a case report","volume":"15","author":"Paboeuf","year":"2019","journal-title":"J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med."},{"key":"10.1016\/j.sleep.2024.09.045_bib55","series-title":"TICAPNEA project","author":"Barras","year":"2024"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945724004660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945724004660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T04:18:38Z","timestamp":1737778718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945724004660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":55,"alternative-id":["S1389945724004660"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2024.09.045","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Signal detection of drugs associated with obstructive and central sleep apnoea","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2024.09.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}